Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin,
President and Chief Executive Officer, will be presenting a corporate
overview at the Fifth Annual Noble Financial Equity Conference on
Tuesday, June 9, 2009 at the Seminole Hard Rock Hotel, Hollywood, FL.
Clinical Data's presentation will take place at 8:05 a.m. EDT.
A live audio and archived webcast of the Company presentation can be
accessed through the Company's website at www.clda.com.
About Clinical Data, Inc.
Clinical Data is a biotechnology company focused on the discovery,
development and commercialization of targeted therapeutics: From
Targeted Science to Better Healthcare®. Clinical Data is
leveraging advances in molecular discovery to provide tangible benefits
for patients, healthcare professionals and payors worldwide. The Company
is advancing its late-stage, first-in-class or potential
best-in-category drug candidates including vilazodone, for the treatment
of depression, and Stedivaze, a vasodilator for cardiac stress imaging,
to be followed by promising drug candidates in other therapeutic areas
such as inflammatory diseases and oncology. Coupled with its biomarker
expertise and portfolio of intellectual property, Clinical Data plans to
develop and commercialize targeted therapeutics, as well as genetic and
pharmacogenomic tests to detect serious diseases and help predict drug
safety, tolerability, and efficacy, thereby improving patient health
while reducing costs. To learn more, please visit the Company's website
at www.clda.com.
Clinical Data, Inc.
Theresa McNeely, 617-527-9933, x3373
Vice
President
Corporate Communications
